Friday 6 November 2026
Export ACH’s income statement to Excel — free account
Accendra Health, Inc.
ACH Healthcare Medical Distribution
Accendra Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.8 billion, up 3.06% from fiscal 2024.
- Revenue
- −10.1%
- EPS
- +89.7%
- Free cash flow
- −1,624.8%
- Total debt
- −13.1%
Quarter to June 2026, against a year earlier
0.27
0.01
−3.57%
Follow ACH
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 72.63% | (2,037.64%) | (1,755.61%) | (602.33%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 4 | 2 | 2 | |
| (9.65%) | (29.76%) | (30.97%) | (29.40%) | ||
ROIC |
1.58% | 1.19% | 1.31% | (10.17%) | |
Return on Tangible Assets |
162.35% | 279.71% | 769.45% | 1,797.67% | |
Average Days of Receivables |
16.56 | 13.94 | 12.67 | 26.93 | |
Free Cash Flow per Share |
(2.75) | (2.03) | (2.93) | (3.60) | |
Free Cash Flow |
(210.90) | (154.99) | (225.15) | (278.42) | |
Capital Expenditures |
(30.49) | (38.19) | (123.36) | (179.44) | |
| Other line items | |||||
Cash ROIC |
(17.95%) | (7.85%) | (12.03%) | (16.20%) | |
Accounts Receivable Turnover |
16.73 | 7.94 | 17.58 | 6.36 | |
Accounts Payable Turnover |
4.11 | 1.67 | 4.07 | (0.35) | |
Inventory Turnover |
20.49 | 1.99 | 20.74 | (0.44) | |
Average Days of Payables |
88.18 | 93.21 | 90.11 | (427.82) | |
Days of Inventory on Hand |
18.33 | 16.23 | 18.45 | (80.40) | |
Tax Rate |
(0.04) | (0.07) | 0.01 | 0.07 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
39.14% | 39.04% | 38.65% | 31.24% | |
Share Based Compensation of Revenue |
0.40% | 0.42% | 0.47% | 0.53% | |
Interest Coverage |
0.24 | 0.22 | 0.26 | (2.78) | |
Operating CF/Net income |
0.60 | 0.11 | 0.09 | 0.07 | |
Depreciation/Fixed assets |
1.23 | 1.02 | 0.84 | 2.23 | |
Capex/Depreciation |
(0.12) | (0.16) | (0.57) | (0.31) | |
Revenue per Share |
34.52 | 35.53 | 35.92 | 35.56 | |
Operating CF per Share |
(2.35) | (1.53) | (1.32) | (1.28) | |
Capex per Share |
(0.40) | (0.50) | (1.60) | (2.32) | |
Capex to Sales |
0.01 | 0.01 | 0.04 | 0.07 |
Columns are period end dates · fundamentals updated 26 Oct 2026